PROTEASE INHIBITORS

Compounds of the formula (I), wherein R1, R2, X and N are as defined in the specification; L is F, NH2, NHAlk or N(Alk)2 n is 1 or 2; A' and A" are terminal groups as defined in the specification. The compounds have utility as HIV-1 protease inhibitors. L'invention concerne des compos...

Full description

Saved in:
Bibliographic Details
Main Authors SUND, CHRISTIAN, WALLBERG, HANS, HALLBERG, ANDERS, LINDBORG, BJOERN, SAMUELSSON, BERTIL, KALAYANOV, GENADIY
Format Patent
LanguageEnglish
French
Published 03.05.2007
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Compounds of the formula (I), wherein R1, R2, X and N are as defined in the specification; L is F, NH2, NHAlk or N(Alk)2 n is 1 or 2; A' and A" are terminal groups as defined in the specification. The compounds have utility as HIV-1 protease inhibitors. L'invention concerne des composés de formule (I), où R1, R2, X et N sont tels que définis dans les spécifications ; L est F, NH2, NHAlk ou N(Alk)2 ; n est 1 ou 2 ; A' et A' sont des groupes terminaux comme définis dans les spécifications. Lesdits composés sont utiles en tant qu'inhibiteurs de protéase du VIH-1.
Bibliography:Application Number: WO2006EP10194